Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Basic Clin Pharmacol Toxicol ; 96(2): 111-7, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15679473

RESUMEN

The aim of the study was to examine antidotal potency of trimedoxime in mice poisoned with three direct dimethoxy-substituted organophosphorus inhibitors. In order to assess the protective efficacy of trimedoxime against dichlorvos, heptenophos or monocrotophos, median effective doses and efficacy half-times were calculated. Trimedoxime (24 mg/kg intravenously) was injected 5 min. before 1.3 LD50 intravenously of poisons. Activities of brain, diaphragmal and erythrocyte acetylcholinesterase, as well as of plasma carboxylesterases were determined at different time intervals (10, 40 and 60 min.) after administration of the antidotes. Protective effect of trimedoxime decreased according to the following order: monocrotophos > heptenophos > dichlorvos. Administration of the oxime produced a significant reactivation of central and peripheral acetylcholinesterase inhibited with dichlorvos and heptenophos, with the exception of erythrocyte acetylcholinesterase inhibited by heptenophos. Surprisingly, trimedoxime did not induce reactivation of monocrotophos-inhibited acetylcholinesterase in any of the tissues tested. These organophosphorus compounds produced a significant inhibition of plasma carboxylesterase activity, while administration of trimedoxime led to regeneration of the enzyme activity. The same dose of trimedoxime assured survival of experimental animals poisoned by all three organophosphorus compounds, although the biochemical findings were quite different.


Asunto(s)
Diclorvos/envenenamiento , Monocrotofos/envenenamiento , Intoxicación por Organofosfatos , Trimedoxima/uso terapéutico , Acetilcolina/química , Acetilcolina/metabolismo , Animales , Química Encefálica/efectos de los fármacos , Carboxilesterasa/antagonistas & inhibidores , Carboxilesterasa/sangre , Carboxilesterasa/efectos de los fármacos , Diafragma/efectos de los fármacos , Diafragma/fisiología , Diclorvos/administración & dosificación , Diclorvos/antagonistas & inhibidores , Evaluación Preclínica de Medicamentos/métodos , Eritrocitos/química , Eritrocitos/efectos de los fármacos , Eritrocitos/fisiología , Inyecciones Intravenosas , Dosificación Letal Mediana , Masculino , Ratones , Monocrotofos/administración & dosificación , Monocrotofos/antagonistas & inhibidores , Compuestos Organofosforados/administración & dosificación , Compuestos Organofosforados/antagonistas & inhibidores , Oximas/administración & dosificación , Oximas/farmacología , Oximas/uso terapéutico , Factores de Tiempo , Trimedoxima/administración & dosificación , Trimedoxima/farmacocinética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA